Improving Care for Uncomplicated URinary Tract Infection-associated Symptoms in Primary Healthcare Settings in INDOnesia
Launched by ERASMUS MEDICAL CENTER · Mar 6, 2024
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to improve how urinary tract infections (UTIs) are treated in primary healthcare settings in Indonesia. Researchers want to see if using a simple test called a urinary dipstick can help doctors make better decisions about prescribing antibiotics for patients with uncomplicated UTIs. The study will also check how well healthcare workers understand the proper use of antibiotics, which is important for preventing antibiotic resistance.
To participate in this trial, you need to be an adult who has a straightforward UTI—not someone who has repeated infections, pregnant, or has taken antibiotics in the last three months. If you join, you can expect to receive care that may help improve the way UTIs are treated in your community, while also contributing to important research that could benefit many others in the future. The trial is not yet recruiting participants, but it aims to provide better care for patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients with uncomplicated urinary tract infection
- Exclusion Criteria:
- • patients who have recurrent episodes of uncomplicated UTI, pregnant women, and patients with recent antibiotic use (any antibiotic use within 3 months before visit)
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, Zuid Holland, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported